Hiroyasu Morikawa
Asahimachi, 5458585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 24, 2020
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Journal: Annals of hepatology
Published: February 15, 2020
Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: December 05, 2018
Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Journal: Clinical journal of gastroenterology
Published: November 15, 2018
Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects.
Journal: Internal medicine (Tokyo, Japan)
Published: September 14, 2018
Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Journal: PloS one
Published: July 25, 2018
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
Journal: Journal of gastroenterology and hepatology
Published: April 21, 2018
Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C.
Journal: United European gastroenterology journal
Published: March 25, 2018
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: March 19, 2018
The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort.
Journal: Journal of viral hepatitis
Published: August 27, 2017
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Journal: PloS one
Published: June 30, 2017
Last Updated: 09/26/2026